SCHEMBL7365905

SCHEMBL7365905

CC(C)(CN(O)C=O)CS(=O)(=O)c1ccc(Oc2ccc(OC(F)(F)F)cc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MMP9 P14780 20/20 0.57
MMP2 P08253 18/20 0.57
MMP1 P03956 7/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7358585 0.87 MMP13 (0.53) MMP9MMP2MMP1
SCHEMBL8005755 0.83 MMP9 (0.59) MMP9MMP2MMP1
SCHEMBL10021363 0.78 MMP9 (0.74) MMP9MMP2MMP1
SCHEMBL8000461 0.77 MMP9 (0.54) MMP9MMP2MMP1
SCHEMBL7539094 0.76 MMP2 (0.65) MMP9MMP2MMP1
SCHEMBL7539103 0.76 MMP2 (0.65) MMP9MMP2MMP1
SCHEMBL8001929 0.76 MMP9 (0.71) MMP9MMP2MMP1
SCHEMBL7365907 0.75 MMP2 (0.48) MMP9MMP2MMP1
SCHEMBL8002778 0.74 MMP9 (0.71) MMP9MMP2MMP1
SCHEMBL7923030 0.73 MMP9 (0.53) MMP9MMP2MMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235786-B1 RHEUMATIC DISORDERS; BONE DISORDERS; ORAL DISEASES; ANTIULCER AGENTS; ANTITUMOR AGENTS ABBOTT LABORATORIES 2001-05-22 US claimed
WO-2000044712-A1 N-HYDROXYFORMAMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES ABBOTT LABORATORIES (US) 2000-08-03 WO claimed
US-6235786-B1 RHEUMATIC DISORDERS; BONE DISORDERS; ORAL DISEASES; ANTIULCER AGENTS; ANTITUMOR AGENTS ABBOTT LABORATORIES 2001-05-22 US disclosed
WO-2000044712-A1 N-HYDROXYFORMAMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES ABBOTT LABORATORIES (US) 2000-08-03 WO disclosed